ATE16489T1 - Aroylimidazolone. - Google Patents

Aroylimidazolone.

Info

Publication number
ATE16489T1
ATE16489T1 AT82101706T AT82101706T ATE16489T1 AT E16489 T1 ATE16489 T1 AT E16489T1 AT 82101706 T AT82101706 T AT 82101706T AT 82101706 T AT82101706 T AT 82101706T AT E16489 T1 ATE16489 T1 AT E16489T1
Authority
AT
Austria
Prior art keywords
aroylimidazolone
aroylimidazole
cardiotonics
ones
acid
Prior art date
Application number
AT82101706T
Other languages
German (de)
English (en)
Inventor
Richard C Dage
Richard A Schnettler
Frank P Palopoli
J Martin Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE16489T1 publication Critical patent/ATE16489T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Luminescent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT82101706T 1981-03-05 1982-03-04 Aroylimidazolone. ATE16489T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use
EP82101706A EP0059948B1 (en) 1981-03-05 1982-03-04 Novel aroylimidazolones

Publications (1)

Publication Number Publication Date
ATE16489T1 true ATE16489T1 (de) 1985-11-15

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82101706T ATE16489T1 (de) 1981-03-05 1982-03-04 Aroylimidazolone.

Country Status (18)

Country Link
US (1) US4405628A (enExample)
EP (1) EP0059948B1 (enExample)
KR (1) KR890000765B1 (enExample)
AT (1) ATE16489T1 (enExample)
AU (1) AU557590B2 (enExample)
CA (1) CA1190550A (enExample)
DE (1) DE3267352D1 (enExample)
DK (1) DK168627B1 (enExample)
ES (2) ES510087A0 (enExample)
GB (1) GB2096600B (enExample)
GR (1) GR76518B (enExample)
HK (1) HK61686A (enExample)
IE (1) IE52387B1 (enExample)
IL (1) IL65137A (enExample)
MY (1) MY8600700A (enExample)
NO (1) NO157175C (enExample)
NZ (1) NZ199885A (enExample)
PH (1) PH18345A (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
ZA855592B (en) * 1984-07-30 1986-03-26 Merrell Dow Pharma The preparation of 1,3-dihydro-4-pyridoyl-2h-imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
EP0536279A1 (en) * 1990-06-29 1993-04-14 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
MX375926B (es) 2013-08-09 2025-03-07 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
DK95482A (da) 1982-09-06
GB2096600A (en) 1982-10-20
IL65137A (en) 1987-02-27
ES8305352A1 (es) 1983-04-16
HK61686A (en) 1986-08-29
AU8103782A (en) 1982-09-09
DK168627B1 (da) 1994-05-09
IE820491L (en) 1982-09-05
ES519254A0 (es) 1984-03-01
NO157175B (no) 1987-10-26
ES8402827A1 (es) 1984-03-01
NO157175C (no) 1988-02-03
US4405628A (en) 1983-09-20
IE52387B1 (en) 1987-10-14
PH18345A (en) 1985-06-05
GB2096600B (en) 1985-06-05
EP0059948A1 (en) 1982-09-15
MY8600700A (en) 1986-12-31
KR890000765B1 (ko) 1989-04-05
NZ199885A (en) 1985-04-30
EP0059948B1 (en) 1985-11-13
IL65137A0 (en) 1982-05-31
CA1190550A (en) 1985-07-16
GR76518B (enExample) 1984-08-10
AU557590B2 (en) 1986-12-24
NO820686L (no) 1982-09-06
KR830009046A (ko) 1983-12-17
ES510087A0 (es) 1983-04-16
DE3267352D1 (en) 1985-12-19

Similar Documents

Publication Publication Date Title
ATE16489T1 (de) Aroylimidazolone.
DE3585981D1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
IL66256A (en) Water containing compositions comprising alkali metal salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
DE3587741D1 (de) Behandlung von Hautkrankheiten.
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
ATE65696T1 (de) Verwendung von defibrotid bei der behandlung von zustaenden akuter nierenschwaeche.
ATE7387T1 (de) Herstellung des calciumsalzes von alpha-hydroxy- gamma-methylmercaptobuttersaeure.
IT7819135A0 (it) Impiego di difenileteri come algicidi.
DK540586D0 (da) Cardiotonisk virksomme thiazoloner
ATE9156T1 (de) Therapeutische zusammenstellungen von imidazolpyridinen.
SE8700555D0 (sv) Purine derivatives, their production and medicaments containing them
DE3686472D1 (de) Cardiotonische phenyloxazolone.
IT1221010B (it) Impiego di chinoloni nel trattamento di malattie cardiache
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES8504182A1 (es) Procedimiento para preparar nuevos derivados de piperidina
ES8505351A1 (es) Un procedimiento para preparar nuevas aroilimidazolonas
GR77250B (enExample)
AR247730A1 (es) Derivados del acido 2, 2-dimetil-ciclopropanocarboxilico y composiciones insecticidas y acaricidas que los contienen, su preparacion, materias primas y procedimiento para obtenerlas
IT1137558B (it) Procedimento per produrre trialogenuri di titanio riducendo teraalogenuri di titanio
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
ATE51899T1 (de) Elektrochemische behandlung von ligninen.
ATE75617T1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
UA24749A1 (uk) Спосіб стимуляції фуhкції кори hадhирhиків
ATE76299T1 (de) Wiederherstellung von gewebe bei tieren.